作者:
Nakasone,H. [1]
;
Kurosawa,S. [2]
;
Yakushijin,K. [3]
;
Taniguchi,S. [4]
;
Murata,M. [5]
;
Ikegame,K. [6]
;
Kobayashi,T. [7]
;
Eto,T. [8]
;
Miyamura,K. [9]
;
Sakamaki,H. [10]
;
Morishima,Y. ;
Nagamura,T. ;
Suzuki,R. ;
Fukuda,T.
作者单位:
Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
[1]
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
[2]
Hematology Division, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital
[3]
Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan
[4]
Department of HSCT Data Management and Biostatistics, Nagoya University, Nagoya, Japan
[5]
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
[6]
Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan, Division
[7]
Working Group for HSCT Complications of the Japan Society for Hematopoietic Cell Transplantation
[8]
Department of Cell Processing and Transfusion, Institute of Medical Science, University of Tokyo
[9]
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya
[10]
发布时间
2013-11-20